SARCULATOR3.0.2 - App Store
You'll be able to see results in few seconds.
Publisher Description
This app is meant to be used only by physicians and it is not meant to make clinical decisions (the clinical usefulness of the two models has not been tested) but to be used as an informative tool to improve the predictive capability of a physician.
Two kinds of predictions are possible:
- RPS: 5-year overall survival (OS) and 5-year disease-free survival (DFS) in primary resected retroperitoneal sarcoma (RPS) patients. .
- ESTS: 5- and 10-year overall survival (OS) and cumulative incidence of distant metastasis (CCI of DM) in primary resected extremity STS patients.
Version History Sarculator now includes BayeSarc, a new Bayesian sequential-learning model for prognosis prediction in patients with extremity soft-tissue sarcoma. 3.0.2 May 1 Update: new model for patients with primary RPS taking into consideration the improved outcome over time and the case-volume effect. 2.2.1 11/06/2023 Update: new model for patients with primary RPS taking into consideration the improved outcome over time and the case-volume effect.
Aggiornamento: nuovo modello per pazienti con sarcomi primitivi del retroperitoneo che tiene in considerazione del miglioramento della prognosi osservata negli anni recenti e l’effetto del volume del centro. 2.2 10/31/2023 Improved interface. New dynamic nomogram to predict prognosis during follow-up in retroperitoneal sarcoma survivors. 2.1.2 07/28/2022 Improved interface. New dynamic nomogram to predict prognosis during follow-up in retroperitoneal sarcoma survivors. 2.1.1 07/27/2022 Improved interface. New dynamic nomogram to predict prognosis during follow-up in retroperitoneal sarcoma survivors. 2.1 07/25/2022 Support for iOS 13 2.0 11/13/2019 New UX/UI and new features 1.5.3 02/01/2018 bug fixes and improvements 1.3.1 02/15/2017 Signin, Signout, Guest User, Save Data, Bug Fixes and improvements 1.3 02/12/2017 bug fixes and improvements 1.2 05/28/2016 performance improved 1.1 01/14/2016 1.0 11/13/2015
About SARCULATOR
The company that develops SARCULATOR is DIGITAL FOREST SRL. The latest version released by its developer is 3.0.2.
To install SARCULATOR on your iOS device, just click the green Continue To App button above to start the installation process. The app is listed on our website since 2026-10-14 and was downloaded 0 times. We have already checked if the download link is safe, however for your own protection we recommend that you scan the downloaded app with your antivirus. Your antivirus may detect the SARCULATOR as malware if the download link is broken.
How to install SARCULATOR on your iOS device:
- Click on the Continue To App button on our website. This will redirect you to the App Store.
- Once the SARCULATOR is shown in the iTunes listing of your iOS device, you can start its download and installation. Tap on the GET button to the right of the app to start downloading it.
- If you are not logged-in the iOS appstore app, you'll be prompted for your your Apple ID and/or password.
- After SARCULATOR is downloaded, you'll see an INSTALL button to the right. Tap on it to start the actual installation of the iOS app.
- Once installation is finished you can tap on the OPEN button to start it. Its icon will also be added to your device home screen.
Program Details
System requirements
Download information
Pricing
Version History
version 3.0.2
posted on 2026-10-14
Version History Sarculator now includes BayeSarc, a new Bayesian sequential-learning model for prognosis prediction in patients with extremity soft-tissue sarcoma. 3.0.2 May 1 Update: new model for patients with primary RPS taking into consideration the improved outcome over time and the case-volume effect. 2.2.1 11/06/2023 Update: new model for patients with primary RPS taking into consideration the improved outcome over time and the case-volume effect.
Aggiornamento: nuovo modello per pazienti con sarcomi primitivi del retroperitoneo che tiene in considerazione del miglioramento della prognosi osservata negli anni recenti e l’effetto del volume del centro. 2.2 10/31/2023 Improved interface. New dynamic nomogram to predict prognosis during follow-up in retroperitoneal sarcoma survivors. 2.1.2 07/28/2022 Improved interface. New dynamic nomogram to predict prognosis during follow-up in retroperitoneal sarcoma survivors. 2.1.1 07/27/2022 Improved interface. New dynamic nomogram to predict prognosis during follow-up in retroperitoneal sarcoma survivors. 2.1 07/25/2022 Support for iOS 13 2.0 11/13/2019 New UX/UI and new features 1.5.3 02/01/2018 bug fixes and improvements 1.3.1 02/15/2017 Signin, Signout, Guest User, Save Data, Bug Fixes and improvements 1.3 02/12/2017 bug fixes and improvements 1.2 05/28/2016 performance improved 1.1 01/14/2016 1.0 11/13/2015
version 2.2.1
posted on 2023-11-06
Update: new model for patients with primary RPS taking into consideration the improved outcome over time and the case-volume effect.
version 2.2.1
posted on 2023-11-06
Nov 6, 2023
Version 2.2.1
Update: new model for patients with primary RPS taking into consideration the improved outcome over time and the case-volume effect.
Disclaimer
Official App Store Link
We do not host SARCULATOR on our servers. We did not scan it for viruses, adware, spyware or other type of malware. This app is hosted by Apple and passed their terms and conditions to be listed there. We recommend caution when installing it.
The App Store link for SARCULATOR is provided to you by apps112.com without any warranties, representations or guarantees of any kind, so access it at your own risk.
If you have questions regarding this particular app contact the publisher directly. For questions about the functionalities of apps112.com contact us.



